Because diabetes is marked by chronic low‐grade inflammation and impaired insulin signaling, the markedly lower CTRP12 levels observed in diabetic CAD patients may reflect a greater inflammatory and metabolic burden [27]. The gene discussed is C1QTNF12; the disease is diabetes mellitus.